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ABSTRACT
Mathematical disease modeling has long operated under the assumption that any one infectious disease is caused by one
transmissible pathogen spreading among a population. This paradigm has been useful in simplifying the biological reality of
epidemics and has allowed the modeling community to focus on the complexity of other factors such as population structure
and interventions. However, there is an increasing amount of evidence that the strain diversity of pathogens, and their interplay
with the host immune system, can play a large role in shaping the dynamics of epidemics. Here, we introduce a disease model
with an underlying genotype network to account for two important mechanisms. One, the disease can mutate along network
pathways as it spreads in a host population. Two, the genotype network allows us to define a genetic distance across strains
and therefore to model the transcendence of immunity often observed in real world pathogens. We study the emergence
of epidemics in this model, through its epidemic phase transitions, and highlight the role of the genotype network in driving
cyclicity of diseases, large scale fluctuations, sequential epidemic transitions, as well as localization around specific strains of
the associated pathogen. More generally, our model illustrates the richness of behaviors that are possible even in well-mixed
host populations once we consider strain diversity and go beyond the “one disease equals one pathogen” paradigm.
1 Introduction
Viral species are known to often undergo rapid evolution. Since the early 20th century, influenza viruses have been described
as having marked variability and unpredictable behavior1. Subsequent RNA virus studies of the 20th and 21st century have
focused on, among others, the Zaire ebolavirus, strains of the SARS-CoV species, and HIV-1, all possessing high mutation
rates2. These frequent mutations contribute to the antigenic evolution of these viruses, allowing them to evade recognition by
the human immune system3.
Despite the long-standing knowledge of subtypes and strains within viral species, mathematical disease modeling has
continued to model viral diseases with one underlying pathogen. Notably, influenza violates the “one disease, one pathogen”
paradigm: numerous types, subtypes, and strains of influenza viruses challenge the human immune system, driving vaccine
effectiveness below 50% in most recent years4–7. Models which fail to account for antigenic variation of a pathogen may lead
to biased characterizations of epidemic emergence and progression.
Modeling multi-strain pathogens with consideration for antigenic properties requires the inclusion of cross-protective
effects, in which the immunity acquired towards one strain offers partial protection towards another strain based on their
antigenic similarity. Cross-protection is seen in numerous viral species8–10. In general, more similar strains will have greater
cross-protective effects, as with seasonal influenza11. However, cross-protective immunity is not necessarily a monotonically
decreasing function of antigenic distance. Antibody-dependent enhancement has been observed in dengue viruses, in which a
past infection may in fact increase the risk of severe infection12, 13. Regardless, approximations of cross-protection may be
made through antigenic distance or genetic distance. This relationship may be determined by a function of genetic distance to
approximate the unique antigenic distances between all strains.
Several models have been proposed in the growing sub-discipline of multistrain disease modeling14. These models balance
biological assumptions with computational tractability through reduction via symmetry (e.g. antigenic neighborhoods15) age
structure16, and deciding to capture either infection history or immune status14 among other modeling choices. Cross-protective
immunity has been explored in two-strain models17, multi-strain models with a restricted number of antigenic loci and alleles18,
and temporary cross-protective immunity in dengue models19 capable of producing cyclical and chaos-like infection progression.
However, the effects of an underlying genotype network structure — governing viable mutation pathways and genetic distances
between strains — have not been thoroughly explored with multistrain models. Genotype networks consist of nodes that
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represent strains, with edges connecting strains that differ by one nucleotide or amino acid in some antigenic region of a gene
or protein20. Genotype networks are a complementary structure to phylogenetic trees, and are a useful way of representing
genetic distance necessary for cross-immunity in multi-strain models.
Moreover, the genotype network gives us a proxy through which we can specify potential mutation pathways between
strains. Mechanisms for pathogen mutation have previously been included in mathematical models21, 22, often to consider the
emergence of antiviral resistance23–26. Particularly, these models predict the emergence of sequential epidemic transitions —
with a first epidemic threshold defining the emergence of macroscopic disease spread and a second marking the emergence of
treatment resistant strain24. However, such models are often limited to only two pathogen strains as they require specification
of the fitness cost associated with resistance. We therefore aim to introduce a more general model, allowing large number of
strains to mutate along specific network pathways. While this general model could consider a complex fitness landscape over
this genotype network, we focus on the case of neutral evolution and show how the previous results discussed here can all
co-exist within a single, fairly simple, model.
We introduce a multistrain Susceptible-Infectious-Recovered-Susceptible (multistrain SIRS) epidemic model with an
underlying genotype network, allowing the disease to evolve along plausible mutation pathways as it spreads in a well-mixed
population. We then investigate the effects of genotype network structure on the emergence of an endemic state and on the
fitness distribution of strains across the genotype network. Altogether, our results challenge the typical phenomenology of
epidemic models. We find two epidemic transitions: one marking the emergence of an endemic state driven by a subset
of strains well localized on the genotype network and one marking a delocalization on the network, where all strains now
contribute to the endemic stain. Between these thresholds, we find chaos-like behavior which can be maintained for arbitrarily
long times, yielding time series with epidemic cycles featuring large unpredictable fluctuations.
2 Model
We study the spread on infectious disease within a well-mixed population for a defined genotype network of the chosen
pathogen. Our model is as follows.
The underlying epidemiological dynamics correspond to a simple SIRS model, but where we add a genotype network
defined as a set of potential mutations, meaning an infection of strain i ∈ [1,N] can mutate along the network to a neighbouring
strain j ∈Ni, whereNi specifies the set of first network neighbours of strain i. Biologically, this network is defined such that
neighbouring strains i and j differ by one unit of genetic distance.
The strains spread within a well-mixed host population. Host individuals are defined as susceptible (S) if they possess no
immunity to any strain of a disease, see Fig. 1. Susceptible individuals progress to infectious state Ii at transmission rate β for
every contact with individuals infectious with strain i, occurring at rate β Ii for every susceptible individual. Note that this basic
transmission rate is held constant for all strains, as we focus on neutral evolution as a first approximation.
Individuals in Ii can either: (i) recover at rate γ to state Ri and acquire direct immunity for strain i and partial immunity to
strain j 6= i; or (ii) become infected with strain I j via mutation at a rate µ for all strains j inNi. Individuals in Ri will either:
(i) lose immunity and progress to S at rate α , or (ii) become infected with strain j 6= i to which they only possessed partial
immunity and progress to I j at a reduced rate β ∗, where β ∗ is an exponentially decaying function of genetic distance between
strains i, j. Specifically:
β ∗ ∝ 1− e−xi j/∆ (1)
where xi j is the genetic distance between strain i, j (approximated by shortest path of length xi j = x ji between strains i, j in the
genotype network) and ∆ is the rate of immunity transcendence (0 < ∆< ∞).
Altogether, the dynamics of our model can be followed by the following set of ordinary differential equations (ODEs),
dS
dt
=−β
N
∑
i=1
SIi
N
+α
N
∑
i=1
Ri (2)
dIi
dt
= β
SIi
N
− γIi+µ
N
∑
j=1
Ai, j(I j− Ii)+β
N
∑
j=1
(
1− e−xi j/∆
) IiR j
N
(3)
dS
dt
= γIi−αRi−β
N
∑
j=1
(
1− e−xi j/∆
) I jRi
N
(4)
where Ai j is an element of the adjacency matrix of the genotype network, equal to 1 if there is mutation pathway between i and
j and 0 otherwise.
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Symbol Parameter
n # strains
N population size
S susceptible
Ii infected (strain i)
Ri recovered (strain i)
β transmission rate
γ recovery rate
α immunity loss rate
µ mutation rate
∆ characteristic length of immunity transcendence
A adjacency matrix of the genotype network
xi j shortest path length between strains i & j
Figure 1. Compartmental model of a multistrain epidemic with an underlying genotype network (left), with parameters
(right).
We therefore have 5 important epidemiological parameters: transmission rate β , recovery rate γ , rate of waning immunity
α , mutation rate µ and immunity transcendence ∆. Unless mentioned otherwise, we typically fix the recovery rate γ = 1 such
that other rates are defined in units of infectious period (and ∆ in units of genetic distance). The other parameters then allow us
to investigate different interesting regimes,
As ∆→ 0, immunity becomes strain specific with no cross-protective effects. As ∆→∞, immunity becomes broad-reaching
to the point of universal protection across all strains. With β ∗ as a function of distance, we are able to reduce model complexity
by avoiding specification of β ∗i j among all strains, whose values may not be known in real-world applications. Instead, we rely
on the inverse relationship between antigenic distance and cross-protection that has been observed in influenza viruses11. Note
that this relationship may not be monotonically decreasing for all pathogens, in which case β ∗ may be defined by a function of
genetic distance unique to the pathogens.
Our most important assumption is perhaps that only the most recent infection is relevant for cross-immunity effects. Indeed,
Ii and Ri specify the pathogen involved only in the most recent infection for every individual. The alternative would have been
to model an infectious state Ii, j,... for all unique infection histories, of complexity O(2n) if order does not matter and complexity
O(n!) if it does. While a big assumption, focusing on the most recent infection reduces the complexity to O(n). Computational
feasibility would be largely restricted, which would limit the analysis of the effects of genotype network structure14, 27. The
infection history approximation enables genotype networks to be large enough to contain complex structure, necessary to
investigate the role of genotype networks in epidemic progression.
3 Results
We focus our attention on the consequences of the genotype network underlying the spread of the disease. In order to gain as
much insights as possible on how it affect prevalence of a disease, we keep the network itself simple using well-known graph
toy models composed of lattices, chains and stars.
3.1 Localization in genotype space
We first ask which strains can be expected to have an advantage, not because of their own fitness or of our epidemiological
parameters (as they all share the same β , γ and α), but because of their position in the genotype network. We use three simple
network structures — a star, a square lattice, and a chain, all containing 25 strains — and run our model to produce a large
outbreak with β = 25 much greater than the expected SIRS epidemics threshold of βc = 1. Accordingly, we set the evolutionary
dynamics to be much slower than that of epidemic spread with µ = 10−3. We then let the system reach its endemic steady state,
where the derivatives in Eqs. (2-4) essentially go to zero such that the system is at equilibrium.
We observe a localization of infections by strain within genotype networks as shown in Fig. 2, top row. Stationary or
endemic infection counts I∗i differ from strain to strain, even with the assumption of neutral evolution, based solely on their
position in the network and the resulting cross-protective immune effects. Epidemics can therefore be localized around a
minority of strains, as is clear in the lattice and chain networks.
We quantify this localization phenomena with Kish’s effective sample size28, referred to here as effective participation ratio
n∗e f f = ne f f /n. As n
∗
e f f → 1, all strains contribute an equal number of infections. As n∗e f f → n−1, only one strain contributes
infections. In Fig. 2, top row, we observe lower n∗e f f in the lattice and chain, indicating greater localization. A small number of
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Figure 2. Infection localization and characteristics of endemic infection state. (Top) Localization within networks shown by
endemic infection counts I∗i normalized by max(I∗i ) for a given network. We use mutation rate µ = 10−3, transmission rate
β = 25, waning immunity rate α = 1/50, and transcending immunity ∆= 4. (Middle) Infection localization regimes are
revealed where normalized effective sample size is low (lattice and chain), occurring when few strains account for the majority
of infections. (Bottom) endemic infections depend on not only transmission rate β , but also the breadth of cross-protective
effects determined by transcendence rate ∆. Fixed parameters are n= 25, µ = 10−3, α = 1/50.
strains are able to escape strong cross-protective immunity in the corners of the lattice and at the ends of the chain, while such
heterogeneity is not seen in the star and ring networks.
As network structure determines infection localization, so does the transcendence of immunity. In Fig. 2, middle row,
we see n∗e f f as a function of β and immunity transcendence ∆, revealing regimes of strong localization in the lattice and
chain networks where n∗e f f remains small. High values of ∆ > 10, indicating far-reaching cross-protection, are associated
with localization in these two networks. The structure of the star and loop networks allow them to escape localization effects
influenced by large ∆.
Stationary infection counts I∗ are also influenced by immunity transcendence ∆. In Fig. 2, bottom row, we see reductions in
I∗ as ∆ increases. As cross-protective effects increase, a higher β becomes necessary to maintain infections. Again we see the
importance of network structure, with different values of ∆ required between networks to affect I∗.
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Figure 3. Bifurcation diagram for the model with varying levels of waning immunity on a star genotype network with 10
strains. We fix the recovery rate to γ = 1, the mutation rate µ = 1/100, the transcending immunity ∆= 10 and we vary the
transmission rate β . (Left) We set the waning immunity rate α ∈ {0,0.02} to illustrate the origin of the immune invasion
threshold (vertical dotted line) obtained with Eqs. (5) and (6). (Right) For large enough values of waning immunity rate, the
immune invasion threshold disappears.
3.2 Sequential phase transitions
We then look at the behaviour of the endemic state as we vary the basic transmission rate β . We know from classic SIRS model
that there should be an epidemic transition at βc = 1, marking a transition between a disease-free phase where the disease is too
weak to establish itself in the population if β < 1, and an endemic phase for larger values. Yet, one interesting result of Fig. 2,
bottom row is that the epidemic threshold now seem to increase with transcending immunity ∆. This is somewhat surprising
given that ∆ does not matter for any one strain, which should still be able to survive on its own following SIRS dynamics once
β > βc = 1.
In Fig. 3, we take a deeper look at the phase diagram under varying transmission rate and observe a second epidemic
transition. More precisely, I∗ is no longer a concave function of transmission rate; it emerges as expected at βc = 1 but has a
new inflection point at a much higher β value. This means that only modest increases in I∗ are seen when β is just above to the
epidemic threshold βc = 1, in contrast to standard SIS-like models in which this regime experiences the most rapid rate of
change in I∗ as a function of β 29.
We conjecture that this second phase transition is governed by what we call the immune invasion threshold, corresponding
to the point at which infected nodes starts to infect recovered nodes (of other strains) effectively. To see this, in Fig. 3, we
compare the bifurcation diagrams of two models: with and without waning immunity. In the latter case, in the stationary state,
a node infected with strain i can only infect recovered nodes of strains j 6= i (since S∗ = 0). The immune invasion threshold βI
can thus be estimated from βc if α 7→ 0. Surprisingly, even though βc = 1 whenever α > 0, it is no longer the case when α = 0.
To derive the immune invasion threshold, let us rewrite the stationary state quantities I∗,R∗ when α = 0. We have
0 =−γI∗i +µ∑
j
Ai jI∗j −µki+β I∗i ∑
j
Ti jR∗j ,
0 = γI∗i −βR∗i ∑
j
Ti jI∗j ,
where Ti j ≡ (1− e−xi j/∆). Isolating R∗i in the second equation and reinjecting the solution in the first one, we obtain a
self-consistent equation for the {I∗i },
I∗i =
∑ jAi jI∗j
γ
µ
(
1−∑ j Ti j
I∗j
∑k TjkI∗k
)
+ ki
. (5)
Interestingly, the {I∗i } do not depend upon β . However, we know that such solution is possible only if I∗i > 0 ∀i, and this
break down at βI when R∗ = ∑iR∗i → 1. Therefore, the immune invasion threshold βI has the following explicit expression
βI = γ∑
i
I∗i
∑ j Ti jI∗j
, (6)
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Figure 4. Integration of the ODEs on three toy genotype networks — the chain, square lattice and star — all with 25 strains.
We fix the recovery rate γ = 1, the mutation rate µ = 1/100, the waning immunity rate α = 1/50 and vary the transmission
rate β under three values of transcending immunity: (a) ∆= 5, (b) ∆= 10, (c) ∆= 50. Close to the inflection point of every I∗
curve (shown in solid lines) we find a maximum in R∗ (shown in dashed lines). This point therefore marks a second activation
threshold, one where the transmission rate is high enough to counteract transcending immunity and spread the outbreak using
the pool of recovered individuals.
where the {I∗i } are evaluated from Eq. (5).
We observe a direct relationship between ∆ and βI. Namely, when ∆→ ∞, Ti j→ 0 for all i, j, hence βI→ ∞, as seen from
Eq. (6). When ∆→ 0, Ti j→ 1 for all i 6= j, and Tii = 0, hence
βI→ γ∑
i
I∗i
∑ j 6=i I j∗
.
For large networks, βI ≈ γ ≡ 1 in the limit ∆→ 0. Therefore, we conclude that increasing ∆ increases the immune invasion
threshold, which makes sense based on intuition alone.
This relationship is shown in Fig. 4 for the three toy networks across multiple values of ∆. As ∆ increases, immunity
becomes wide-reaching in genetic distance, approaching the effects of universal immunity or a universal vaccine. This has the
effect of necessitating higher β to produce the same I∗ as lower values of ∆. Importantly, because of the sum in the denominator
of Eq. (6), the immune invasion threshold βI is not simply set by the diameter of the genotype network (i.e., the maximum value
of xi j), and is instead set by the entire network structure. While strains maximally distant from each other can of course better
infect recovered individuals, competition between strains also play an important role: central strains can still infect individuals
and grant them better immunity due to their central position in the network. Thus, the network structure plays a nontrivial role
in setting the exact value of βI as determined by Eq. (6).
3.3 Rich dynamics in between epidemic thresholds
Beyond the features of the endemic state, we observe rich prevalence dynamics throughout the epidemic when transmission
rates are between the epidemic threshold βc = 1 and the immune invasion threshold βI ≥ βc. By comparing the top, middle, and
bottom rows of Fig. 5 we see infection counts throughout the epidemic simulation while the transmission rate lays in different
regimes, decreasing from β > βI to values closer to βc = 1.
For transmission rate below the immune invasion threshold (bottom two rows), we see oscillations in the overall infection
counts across all three networks before converging on an endemic value, resembling a dampened pseudo-chaotic behavior.
Noting the different time scales shown, the chain rapidly converges on its endemic state while the star undergoes drastic
oscillations before convergence. We see variation in infection counts at the strain level, with the infection counts for 3 of the 25
strains shown. At the strain level we see convergence occurring on different time scales within the same network, as well as
variability in oscillatory nature.
In comparison, the top row of Fig. 5 shows the rapid convergence on the endemic state when the transmission rate is high
(β = 25). There still exists infection localization, as indicated by different endemic infection counts at the strain level, as well
as variability in convergence time between strains. However, the oscillatory nature is profoundly absent at transmission rates
well about βI. In contrast, as transmission rates are lowered towards βc = 1 in the bottom rows of Fig. 5, we see the oscillations
preserved but stretched across a broader timescale. Importantly, as the timescale of oscillations is stretched, their minimal
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Figure 5. Integration of the ODEs on three toy genotype networks — the chain (left column), square lattice (middle column)
and star (right column) — all with 25 strains. We fix the recovery rate γ = 1, the mutation rate µ = 1/1000, the waning
immunity rate α = 1/5000 and the transcending immunity ∆= 4 and vary the transmission rate: β = 25 (top), β = 1.7
(middle), β = 1.1 (bottom). The system is initialized with a small fraction 10−5 of infections on an “end strain” (end for the
chain, corner for the lattice, leaf for the star). On the chain we see successive activation of all strains, with the system
stabilizing once the entire network is explored and evolution reaches a dead-end. The star sees cycles caused by activation of
the leaf strains. The lattice is much more interesting, with loops causing a random-like succession of strains to cycle. The
dynamics become more interesting for the bottom row, with transmission rates between the epidemic and immune invasion
thresholds, with cycles and chaos-like dynamics. The closer we get to the true epidemic thresholds βc = 1, the longer the
interesting transient dynamics.
values decrease by orders of magnitude. In practice, this shows that any finite size simulations of the dynamics captured by our
model would likely lead to strain extinction, with potential to reemerge through mutations. Discrete events are unfortunately
not captured in ODE models as they assume continuous values, or infinite population.
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4 Conclusion
The introduction of an underlying genotype network to a multistrain model has demonstrated the emergence of cyclicity,
infection localization, and sequential phase transitions, all in one model. Simple mathematical arguments have allowed us to
solve for the transitions observed and highlight the nontrivial impact of the structure of the genotype network. Rich infection
dynamics are seen between the epidemic threshold and the immune invasion threshold. Altogether, what these results show
is that many features of infectious disease dynamics often explained by environmental factors or host behaviour, such as
cyclicity30, unpredictability31 and sequential transitions32, can also be explained by adding a layer of biological complexity in
the form of a genotype network. Our results thus highlight the importance of going beyond the “one disease, one pathogen"
paradigm, with complex dynamics emerging from even the most simple genotype network structures.
Future work needs to be done to integrate this modelling approach with real genomic data. Likewise, the interplay of our
results with the finite size and the contact structure of the host population needs to be investigated; as does the role of strain
extinction and emergence. Different modelling approaches will need to be considered, such as explicitly modeling the growth
and evolution of the genotype network as it co-evolves (albeit on a different timescale) with the spread of the infectious disease
in the host population. Coupling the large modeling literature on growing networks33 with that of network epidemiology29
should lead to a richer understanding of how networks, both biological and social, impact epidemics. Finally, this type of
models could also be appropriate to re-imagine vaccination strategies. The literature on targeted immunization and influential
spreaders on networks could then be leveraged34–37, but rather than targeting central individuals the objective would be to best
hinder and block the immune evasion of the pathogen as it mutates along its genotype network.
In terms of applying these models to specific scenarios, there is a need for unbiased pathogen genomic data, as well as an
understanding of their antigenic properties, to inform models that account for these features using real-world data and to refine
the cross-protective immune effects between strains of a pathogen. Similarly, we need more realistic models to take advantage
of the growing body of genomic data available and refine the mechanisms driving mutation and immunity. We call for the
refinement of immune mechanisms and immune history to allow their incorporation in mathematical disease models. Further
understanding of how pathogens explore genotype space, the growth of genotype networks, the role of host immunity towards
past strains, and the influence of the above on the fitness landscape of pathogens will better inform models incorporating
multiple strains, cross-protective effects, and evolution of a pathogen.
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